Lexicon Pharmaceuticals (LXRX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Lexicon Pharmaceuticals (LXRX) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Lexicon Pharmaceuticals

· LXRX

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

809.82 M

-4.40%

General

Market Cap: $809.82M
Enterprise Value: $791.26M
Shares Outstanding: 444,200,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 98.85%
Operating Margin: -131.43%
Net Profit Margin: -147.38%
FCF Margin: -192.24%
ROA: -24.44%
ROE: -40.40%
ROIC: -23.00%
Current Ratio: 13.37
Debt-to-Equity: 0.34
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 18.64
P/FCF: —
P/B: 4.43
EV/EBITDA: -15.14

Growth

Rev 1Y: 60.24%
Rev 1Y Fwd Est: -25.37%
Rev 3Y (CAGR): 610.25%
Rev 5Y (CAGR): 15.72%
Rev 10Y (CAGR): -9.15%
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $41.47M
Gross Margin: 98.85%
Operating Expenses: $95.5M
Operating Income: -$54.5M
Net Profit: -$61.12M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $40.92M
Working Capital: $181.87M
Total Assets: $250.06M
Net Debt: $18.36M
Total Liabilities: $75.54M
Total Equity: $174.53M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$79.72M
Cash Flow from Investing: -$100.03M
Cash Flow from Financing: $174.07M
Free Cash Flow: -$79.72M
Capital Expenditures: $0